Burning Rock Biotech (BNR) Net Income towards Common Stockholders (2019 - 2026)

Burning Rock Biotech (BNR) has reported Net Income towards Common Stockholders for 8 consecutive years, with -$2.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 35.98% year-over-year to -$2.5 million; the TTM figure through Mar 2026 stood at -$8.4 million (up 74.53% YoY), while the FY2025 annual figure was -$2.2 million, up 80.83% from the prior year.
• Net Income towards Common Stockholders came in at -$2.5 million for Q1 2026 at Burning Rock Biotech, down from -$2.2 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was -$1.4 million in Q2 2025, with the low at -$41.2 million in Q1 2022.
• Average Net Income towards Common Stockholders over 5 years is -$17.3 million, with a median of -$16.8 million recorded in 2024.
• Across the five-year window, Net Income towards Common Stockholders tumbled 57.61% in 2022 and jumped 90.89% in 2025, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$31.4 million in 2022, then increased by 27.12% to -$22.8 million in 2023, then soared by 50.47% to -$11.3 million in 2024, then surged by 80.57% to -$2.2 million in 2025, then retreated by 15.14% to -$2.5 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$2.5 million, -$2.2 million, and -$2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.